Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.45M | 48.48M | 43.37M | 48.56M | 50.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.45M | 48.48M | 43.37M | 48.56M | 50.75M |
| Cost of Revenue | 37.34M | 36.43M | 33.75M | 36.94M | 37.94M |
| Gross Profit | 10.11M | 12.06M | 9.62M | 11.62M | 12.81M |
| SG&A Expenses | 6.52M | 6.47M | 7.12M | 6.89M | 6.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.81M | 45.72M | 43.73M | 46.15M | 47.10M |
| Operating Income | 632.00K | 2.76M | -357.00K | 2.41M | 3.65M |
| Income Before Tax | -663.00K | -10.21M | -1.75M | 1.11M | 2.45M |
| Income Tax Expenses | -192.00K | -2.75M | -504.00K | 243.00K | 567.00K |
| Earnings from Continuing Operations | -471.00K | -7.45M | -1.25M | 870.00K | 1.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00K | 31.00K | 27.00K | 9.00K | -14.00K |
| Net Income | -451.00K | -7.42M | -1.22M | 879.00K | 1.87M |
| EBIT | 632.00K | 2.76M | -357.00K | 2.41M | 3.65M |
| EBITDA | 1.95M | 4.07M | 1.06M | 3.83M | 5.01M |
| EPS Basic | -0.03 | -0.45 | -0.07 | 0.05 | 0.11 |
| Normalized Basic EPS | 0.01 | 0.12 | -0.04 | 0.05 | 0.10 |
| EPS Diluted | -0.03 | -0.45 | -0.07 | 0.05 | 0.11 |
| Normalized Diluted EPS | 0.01 | 0.12 | -0.04 | 0.05 | 0.10 |
| Average Basic Shares Outstanding | 16.66M | 16.65M | 16.65M | 16.64M | 16.63M |
| Average Diluted Shares Outstanding | 16.66M | 16.65M | 16.65M | 16.66M | 16.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |